Predictive values of acute phase reactants, basic fetoprotein, and immunosuppressive acidic protein for staging and survival in renal cell carcinoma

Urology

Volumn 58, Issue 2, 2001, Pages 161-164

  Miyata, Yasuyoshi ^a   Koga, Shigehiko ^a   Nishikido, Masaharu ^a   Noguchi, Mitsuru ^a   Kanda, Shigeru ^a   Hayashi, Tomayoshi ^b   Saito, Yutaka ^a   Kanetake, Hiroshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; FETOPROTEIN; IMMUNOSUPPRESSIVE ACID PROTEIN;

ACCURACY; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CORRELATION FUNCTION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS;

ADULT; AGED; C-REACTIVE PROTEIN; CARCINOMA, RENAL CELL; FEMALE; FERRITINS; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM PROTEINS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0034904305     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)01165-7     Document Type: Article

References (16)

1. Erythrocyte sedimentation rate as a prognostic factor in renal cell carcinoma
2. Erythrocyte sedimentation rates in patients with renal cell carcinoma
3. Serum protein profiles in carcinoma of the kidney
4. Serum basic fetoprotein in patients with renal cell carcinoma
5. Serum immunosuppressive acidic protein in renal cell carcinoma
6. Changes in serum immunosuppressive acidic protein following surgery in patients with renal carcinoma
7. Serum ferritin: A tumor marker for renal cell carcinoma
8. Serum ferritin as a clinical marker for renal cell carcinoma: Influence of tumor volume
9. The results of radical nephrectomy for renal cell carcinoma
10. General rule of clinical and pathological studies on renal cell carcinoma, in Japan Radiological Society
11. Plasma carcinoembryonic antigen in renal cell carcinoma patients
12. Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinoma
13. Serum l]evel of interleukin-6 as a prognostic factor in metastatic renal cell carcinoma
14. DNA content and prognosis in renal cell carcinoma: A comparison between primary tumor and metastases
15. Serum acute phase reactants and prognosis in renal cell carcinoma
16. Prognostic indicators for renal cell carcinoma: A multivariate analysis of 643 patients using the revised 1997 TNM staging criteria